Titrating GLP-1s Safely: The 16–20 Week Schedule Explained

If you start a GLP-1 at the therapeutic dose, there is a good chance you will spend a week in the bathroom and quit. FDA-approved titration schedules are designed to let your gut adapt gradually. Our GLP-1 dosage schedule calculator maps out week-by-week doses based on FDA labeling so you can see the full ramp. This post walks through why the schedule looks the way it does.

Why Titration Exists

GLP-1 receptor agonists slow gastric emptying, reduce appetite, and alter gut motility. At therapeutic doses started cold, common effects include intense nausea, vomiting, diarrhea, and reflux. Gradual dose escalation gives the gastrointestinal system time to adapt. This significantly improves the probability of reaching and tolerating the effective dose long-term.

In STEP 1 and SURMOUNT-1, the titration schedules used in the trials matched the eventual FDA label — they are not arbitrary.

Wegovy (Semaglutide 2.4 mg) Schedule

Per FDA labeling for Wegovy, the standard escalation is:

• Weeks 1-4: 0.25 mg once weekly
• Weeks 5-8: 0.5 mg once weekly
• Weeks 9-12: 1.0 mg once weekly
• Weeks 13-16: 1.7 mg once weekly
• Week 17+: 2.4 mg once weekly (maintenance)

Total ramp: 16 weeks to reach maintenance dose. If side effects at any step are poorly tolerated, the prescriber may hold the current dose longer or step back temporarily.

Zepbound (Tirzepatide) Schedule

Per FDA labeling for Zepbound, the standard escalation is:

• Weeks 1-4: 2.5 mg once weekly
• Weeks 5-8: 5.0 mg once weekly
• Weeks 9-12: 7.5 mg once weekly
• Weeks 13-16: 10 mg once weekly
• Weeks 17-20: 12.5 mg once weekly
• Week 21+: 15 mg once weekly (maximum maintenance dose)

Effective maintenance doses per label are 5, 10, or 15 mg — your prescriber may stop ramping at the lowest dose that produces adequate results.

When to Slow Down

Clinical guidelines and prescriber experience suggest considering a slower ramp or dose hold if:

• Nausea remains moderate-to-severe after 1-2 weeks at a given dose
• Vomiting occurs more than once per week
• You cannot maintain adequate hydration or nutrition
• You experience significant constipation or diarrhea
• You develop abdominal pain (requires evaluation to rule out pancreatitis or gallbladder issues)

Staying at a lower dose longer is often better than pushing through severe symptoms. Some patients achieve excellent weight loss at sub-maximal doses.

Missed Doses

Per FDA labeling:

• Wegovy and Zepbound: If the missed dose is within 5 days of the scheduled day, take it when remembered. If more than 5 days have passed, skip and resume on the normal schedule. Do not double up.

If more than 2 weeks of doses are missed, the prescriber may reinitiate at a lower dose to re-establish tolerance.

Switching Between GLP-1s

If switching from semaglutide to tirzepatide (or vice versa), there is no official equivalence conversion. Most prescribers restart titration from the lowest dose of the new medication to gauge tolerability, though the ramp may move more quickly if the patient already tolerated comparable exposure on the prior drug. This is a clinical judgment call.

Side Effect Management During Titration

Supportive strategies that may help:

• Smaller, more frequent meals — large meals often trigger nausea
• Low-fat, low-fiber meals during the first few days after a dose
• Adequate hydration — often 2-3 liters per day
• Avoiding alcohol, especially in the first 48 hours after injection
• Ginger, peppermint, or antiemetics for nausea (discuss with prescriber)
• Fiber supplements and stool softeners for constipation
• Tracking symptoms so patterns can be shared with your prescriber

When to Seek Medical Attention

Per FDA labeling, contact a clinician promptly for:

• Severe or persistent abdominal pain (possible pancreatitis)
• Right upper quadrant pain, nausea with fever (possible gallbladder issues)
• Signs of severe dehydration (dizziness, low urine output, confusion)
• Neck lump or persistent hoarseness (thyroid concern)
• Vision changes in patients with diabetic retinopathy
• Suicidal ideation or significant mood changes

Maintenance Dose Selection

Not everyone needs the maximum dose. Many patients achieve clinically meaningful weight loss at:

• Semaglutide 1.7 mg (rather than 2.4 mg)
• Tirzepatide 5 or 10 mg (rather than 15 mg)

The lowest effective dose is often the goal — it balances weight-loss response, side-effect profile, and cost.

Long-Term Use

Once at maintenance, most patients remain on the same weekly dose indefinitely, with periodic clinical review. Abrupt discontinuation is associated with significant weight regain, so if stopping is necessary, a structured taper and lifestyle support plan is typically advised.

Next Steps

Use the GLP-1 dosage schedule calculator to visualize the full 16-20 week ramp for Wegovy or Zepbound. Bring the schedule to your prescriber appointment so you both start with the same mental model. If side effects during titration concern you, contact your prescriber — not a forum, and not an anonymous Telehealth chatbot.